Periactin and Nicoderm cq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Periactin and Nicoderm cq together.

The phase IV clinical study analyzes what interactions people who take Periactin and Nicoderm cq have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 24, 2023

3 people who take Periactin and Nicoderm cq together, and have interactions are studied.


What is Periactin?

Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,101 Periactin users for its effectiveness, alternative drugs and more.

What is Nicoderm cq?

Nicoderm cq has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 17,567 Nicoderm cq users for its effectiveness, alternative drugs and more.

Number of Periactin and Nicoderm cq reports submitted per year:

Periactin and Nicoderm cq drug interactions.

Common Periactin and Nicoderm Cq drug interactions by gender *:

female:

n/a

male:

  1. Abdominal abscess
  2. Abdominal mass
  3. Haemoptysis
  4. Hyperhidrosis
  5. Infective pulmonary exacerbation of cystic fibrosis
  6. Intestinal perforation
  7. Liver abscess
  8. Abdominal pain lower
  9. Adrenal insufficiency
  10. Bowel movement irregularity

Common Periactin and Nicoderm Cq drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cough
  2. Dyspnoea exertional
  3. Haemoptysis
  4. Hyperhidrosis
  5. Infective pulmonary exacerbation of cystic fibrosis
  6. Chills

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug toxicity

60+:

  1. Abdominal abscess
  2. Abdominal mass
  3. Abdominal pain lower
  4. Adrenal insufficiency
  5. Bowel movement irregularity
  6. Confusional state
  7. Intestinal perforation
  8. Liver abscess

* Approximation only. Some reports may have incomplete information.

Do you take Periactin and Nicoderm cq?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Periactin and Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Periactin side effects:

Browse all side effects of Periactin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nicoderm cq side effects:

Browse all side effects of Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Periactin interactions:

Browse all interactions between Periactin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nicoderm cq interactions:

Browse all interactions between Nicoderm cq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyproheptadine hydrochloride and nicotine (the active ingredients of Periactin and Nicoderm cq, respectively), and Periactin and Nicoderm cq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Periactin and Nicoderm cq.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: